Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study

Cancer Detection and Prevention

Volumn 27, Issue 1, 2003, Pages 30-36

  Grabrick, Dawn M ^a   Cerhan, James R ^a   Vierkant, Robert A ^a   Therneau, Terry M ^a   Cheville, John C ^a   Tindall, Donald J ^a   Sellers, Thomas A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer; Familial aggregation; Prostate cancer

Indexed keywords

EID: 0037227161     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00176-9     Document Type: Article

References (40)

1. Lopez-Otin C, Diamandis EP. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 1998;19:365-96.
2. Macklin MT. The genetic basis of human mammary cancer. In: AC Society, editor. Proceedings of Second National Cancer Conference. New York: American Cancer Society; 1954. p. 1074-87.
3. Thiessen EU. Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer 1974;34:1102-7
4. Tulinius H, Egilsson V, Olafsdottir GH, et al. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ 1992;305:855-7.
5. Anderson DE, Badzioch MD. Familial breast cancer risks. Effects of prostate and other cancers. Cancer 1993;72:114-9.
6. Goldgar DE, Easton DF, Cannon-Albright LA, et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
7. Sellers TA, Potter JD, Rich SS, et al. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 1994;86:1860-5.
8. Tulinius H, Olafsdottir GH, Sigvaldason H, et al. Neoplastic diseases in families of breast cancer patients. J Med Genet 1994;31:618-21.
9. Cerhan JR, Parker AS, Putnam SD, et al. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999;8:53-60.
10. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001;92:144-50.
11. Andrieu N, Clavel F, Auquier A, et al. Association between breast cancer and family malignancies. Eur J Cancer 1991;27:244-8.
12. Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, et al. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995;87:991-6.
13. Negri E, Braga C, La Vecchia C, et al. Family history of cancer and risk of breast cancer. Int J Cancer 1997;72:735-8.
14. Damber L, Gronberg H, Damber JE. Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden. Int J Cancer 1998;78:293-7.
15. Arason A, Barkardottir RB, Egilsson V. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet 1993;52:711-7.
16. Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-5.
17. Langston AA, Stanford JL, Wicklund KG, et al. Germ-line BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet 1996;58:881-4.
18. Gudmundsson J, Johannesdottir G, Arason A, et al. Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet 1996;58:749-56.
19. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-9.
20. Easton DF, Steele L, Fields P, et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997;61:120-8.
21. Sigurdsson S, Thorlacius S, Tomasson J, et al. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 1997;75:758-61.
22. Thorlacius S, Sigurdsson S, Bjarnadottir H, et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 1997;60:1079-84.
23. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999;91:1310-16.
24. Gayther SA, de Foy KA, Harrington P, et al. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. Cancer Res 2000;60:4513-8.
25. Eerola H, Pukkala E, Pyrhonen S, et al. Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland). Cancer Causes Control 2001;12:739-46.
26. Johannesdottir G, Gudmundsson J, Bergthorsson JT, et al. High prevalence of the 999de15 mutation in icelandic breast and ovarian cancer patients. Cancer Res 1996;56:3663-5.
27. Lehrer S, Fodor F, Stock RG, et al. Absence of 185de1AG mutation of the BRCA1 gene and 6174de1T mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Br J Cancer 1998;78:771-3.
28. Nastiuk KL, Mansukhani M, Terry MB, et al. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. The Prostate 1999;40:172-7.
29. Uchida T, Wang C, Sato T, et al. BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer. Int J Cancer 1999;84:19-23.
30. Wilkens EP, Freije D, Xu J, et al. No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer. The Prostate 1999;39:280-4.
31. Sinclair CS, Berry R, Schaid D, et al. BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res 2000;60:1371-5.
32. Johannsson O, Loman N, Moller T, et al. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J Cancer 1999;35:1248-57.
33. Vazina A, Baniel J, Yaacobi Y, et al. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. Br J Cancer 2000;83:463-6.
34. Sellers TA, King RA, Cerhan JR, et al. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev 1999;8:1051-7.
35. Sellers TA, Anderson VE, Potter JD, et al. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods. Genet Epidemiol 1995;12:417-29.
36. Anderson VE, Goodman, HO, Reed SC. Variables related to human breast cancer. Minneapolis: University of Minnesota Press; 1958.
37. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989;84:1074-8.
38. Zheng L, Li S, Boyer TG. Lessons learned from BRCA1 and BRCA2. Oncogene 2000;19:6159-75.
39. Kerber RA, Slattery ML. Comparison of self-reported and database linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244-8.
40. Airewele G, Adatto P, Cunningham J, et al. Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst 1998;90:543-4.